Yiheng Capital Management, L.P. Akero Therapeutics, Inc. Transaction History

Yiheng Capital Management, L.P.

$380 Million
Q3 2025

A detailed history of Yiheng Capital Management, L.P. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Yiheng Capital Management, L.P. holds 191,076 shares of AKRO stock, worth $10.4 Million. This represents 2.39% of its overall portfolio holdings.

Number of Shares

191,076

Previous 299,791 36.26%

Holding current value

$10.4 Million

Previous $16 Million 43.29%

% of portfolio

2.39%

Previous 1.54%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$42.18 - $54.33 $4.59 Million - $5.91 Million	-108,715 Reduced 36.26%	191,076 $9.07 Million
Q2 2025 Aug 14, 2025	SELL	$34.04 - $56.28 $2.04 Million - $3.38 Million	-60,000 Reduced 16.68%	299,791 $16 Million
Q1 2025 May 15, 2025	SELL	$21.87 - $57.56 $6.7 Million - $17.6 Million	-306,354 Reduced 45.99%	359,791 $14.6 Million
Q4 2024 Feb 11, 2025	SELL	$26.75 - $35.28 $2.48 Million - $3.27 Million	-92,624 Reduced 12.21%	666,145 $18.5 Million
Q3 2024 Nov 12, 2024	SELL	$21.45 - $29.34 $14.5 Million - $19.8 Million	-675,410 Reduced 47.09%	758,769 $21.8 Million

Q1 2024 May 15, 2024	SELL	$17.76 - $31.18 $8.69 Million - $15.3 Million	-489,495 Reduced 25.45%	1,434,179 $36.2 Million
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $7.99 Million - $35.3 Million	702,000 Added 57.46%	1,923,674 $44.9 Million
Q3 2023 Nov 14, 2023	BUY	$41.19 - $52.25 $827,218 - $1.05 Million	20,083 Added 1.67%	1,221,674 $61.8 Million
Q2 2023 Aug 14, 2023	BUY	$36.89 - $56.88 $2.8 Million - $4.31 Million	75,800 Added 6.73%	1,201,591 $56.1 Million
Q1 2023 May 15, 2023	SELL	$37.27 - $50.24 $12.8 Million - $17.2 Million	-343,114 Reduced 23.36%	1,125,791 $43.1 Million
Q4 2022 Feb 14, 2023	SELL	$33.44 - $54.8 $21.1 Million - $34.5 Million	-630,241 Reduced 30.02%	1,468,905 $80.5 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $2.2 Million - $7.37 Million	216,448 Added 11.5%	2,099,146 $71.5 Million
Q2 2022 Aug 15, 2022	BUY	$8.0 - $15.01 $2.64 Million - $4.95 Million	329,708 Added 21.23%	1,882,698 $17.8 Million
Q1 2022 May 16, 2022	BUY	$12.97 - $22.26 $24,643 - $42,294	1,900 Added 0.12%	1,552,990 $22 Million
Q4 2021 Feb 14, 2022	BUY	$19.87 - $26.24 $594,113 - $784,576	29,900 Added 1.97%	1,551,090 $32.8 Million
Q3 2021 Nov 15, 2021	BUY	$18.65 - $25.46 $414,999 - $566,535	22,252 Added 1.48%	1,521,190 $34 Million
Q2 2021 Aug 16, 2021	BUY	$24.81 - $32.35 $30.5 Million - $39.8 Million	1,230,656 Added 458.72%	1,498,938 $37.2 Million
Q1 2021 May 17, 2021	BUY	$24.04 - $34.19 $6.45 Million - $9.17 Million	268,282 New	268,282 $7.78 Million

Others Institutions Holding AKRO

# of Institutions

298

Shares Held

91.4M

Call Options Held

1.04M

Put Options Held

372K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $2.52B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Yiheng Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Yiheng Capital Management, L.P. with notifications on news.

Account

Yiheng Capital Management, L.P. Akero Therapeutics, Inc. Transaction History